Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
TSX:VPH
Price:
0.105 CAD
-8.7%
Market Closed
Updated:
May 3, 2024
Valeo Pharma Inc
Cash from Financing Activities
|
Valeo Pharma Inc
Cash from Financing Activities Peer Comparison
Comparables:
BHC
TH
K
GUD
EDT
CPH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Valeo Pharma Inc
TSX:VPH
|
Cash from Financing Activities
CA$6.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Financing Activities
$1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Theratechnologies Inc
TSX:TH
|
Cash from Financing Activities
$14.7m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash from Financing Activities
-CA$81m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Financing Activities
CA$5.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Cash from Financing Activities
-$5.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is Valeo Pharma Inc's Cash from Financing Activities?
Cash from Financing Activities
6.2m
CAD
6.2m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Cash from Financing Activities amounts to 6.2m CAD.
What is Valeo Pharma Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
37%
37%
Over the last year, the Cash from Financing Activities growth was -89%. The average annual Cash from Financing Activities growth rates for Valeo Pharma Inc have been -12% over the past three years , 37% over the past five years .
You don't have any saved screeners yet
